• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗黑色素瘤分化相关蛋白5阳性皮肌炎中重症间质性肺疾病风险预测:STRAD-Ro52模型

Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model.

作者信息

Xiao Fei, Chen Feilong, Li DongSheng, Zheng Songyuan, Liang Xiao, Wu Juan, Zhong JunYuan, Tan Xiangliang, Chen Rui, Zhu Junqing, Chen Shixian, Li Juan

机构信息

Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, China.

出版信息

Ann Med. 2025 Dec;57(1):2440621. doi: 10.1080/07853890.2024.2440621. Epub 2024 Dec 19.

DOI:10.1080/07853890.2024.2440621
PMID:39697063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11660418/
Abstract

OBJECTIVE

Anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated interstitial lung disease (MDA5DM-ILD) often leads to acute respiratory failure and endangers lives. This study quantitatively analysed chest high-resolution computed tomography (HRCT) images to assess MDA5DM-ILD and establish a risk prediction model for severe ILD within six months.

METHODS

We developed a 'Standardized Threshold Ratio Analysis & Distribution' (STRAD) to analyse lung HRCT images. In this retrospective study, 51 patients with MDA5DM-ILD were included and divided into severe-ILD and non-severe-ILD groups based on the occurrence of acute respiratory failure within six months post-diagnosis of MDA5DM. The STRAD parameters, clinical indicators and treatments were compared between the two groups. Least absolute shrinkage and selection operator (LASSO) regression was used to select the optimal STRAD parameters. Multivariate analysis selected clinical factors to be further combined with STRAD to enhance the predictive performance of the final model (STRAD-Ro52 model).

RESULTS

Significant differences were observed between the two groups in STRAD parameters, anti-Ro52 antibody titers, presence of anti-Ro52 antibodies, age, ESR, ALB, Pa/FiO, IgM and IL-4 levels. The STRAD parameters were significantly correlated with demographic, inflammatory, organ function and immunological indicators. Lasso logistic regression analysis identified the -699 to -650 HU lung tissue proportion (%V7) as the optimal parameter for predicting severe ILD and S6·%V7, and the distribution of %V7 in the mid lungs was the optimal space parameter. Multifactorial regression of clinical indicators showed that the presence of anti-Ro52 antibodies was an independent risk factor for severe ILD, leading to the establishment of the STRAD-Ro52 model.

CONCLUSIONS

The STRAD-Ro52 model assists in identifying MDA5DM patients at risk of developing severe ILD within six months, further optimizing precise disease management and clinical research design.

摘要

目的

抗黑色素瘤分化相关基因5阳性皮肌炎相关间质性肺病(MDA5DM-ILD)常导致急性呼吸衰竭并危及生命。本研究对胸部高分辨率计算机断层扫描(HRCT)图像进行定量分析,以评估MDA5DM-ILD,并建立6个月内严重ILD的风险预测模型。

方法

我们开发了一种“标准化阈值比率分析与分布”(STRAD)方法来分析肺部HRCT图像。在这项回顾性研究中,纳入了51例MDA5DM-ILD患者,并根据MDA5DM诊断后6个月内急性呼吸衰竭的发生情况分为严重ILD组和非严重ILD组。比较两组的STRAD参数、临床指标和治疗情况。采用最小绝对收缩和选择算子(LASSO)回归来选择最佳的STRAD参数。多变量分析选择临床因素,进一步与STRAD相结合,以提高最终模型(STRAD-Ro52模型)的预测性能。

结果

两组在STRAD参数、抗Ro52抗体滴度、抗Ro52抗体的存在、年龄、血沉、白蛋白、动脉血氧分压/吸入氧分数、IgM和IL-4水平方面存在显著差异。STRAD参数与人口统计学、炎症、器官功能和免疫指标显著相关。Lasso逻辑回归分析确定-699至-650 HU肺组织比例(%V7)为预测严重ILD的最佳参数,以及S6·%V7,且%V7在肺中部的分布为最佳空间参数。临床指标的多因素回归显示,抗Ro52抗体的存在是严重ILD的独立危险因素,从而建立了STRAD-Ro52模型。

结论

STRAD-Ro52模型有助于识别在6个月内有发生严重ILD风险的MDA5DM患者,进一步优化精准疾病管理和临床研究设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/dfe8b09584f1/IANN_A_2440621_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/55744aa03468/IANN_A_2440621_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/4cff79742b70/IANN_A_2440621_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/59187c947e03/IANN_A_2440621_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/dfe8b09584f1/IANN_A_2440621_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/55744aa03468/IANN_A_2440621_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/4cff79742b70/IANN_A_2440621_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/59187c947e03/IANN_A_2440621_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cd/11660418/dfe8b09584f1/IANN_A_2440621_F0004_C.jpg

相似文献

1
Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model.抗黑色素瘤分化相关蛋白5阳性皮肌炎中重症间质性肺疾病风险预测:STRAD-Ro52模型
Ann Med. 2025 Dec;57(1):2440621. doi: 10.1080/07853890.2024.2440621. Epub 2024 Dec 19.
2
Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.抗 Ro52 抗体是皮肌炎并发间质性肺病的独立危险因素。
Respir Med. 2020 Oct;172:106134. doi: 10.1016/j.rmed.2020.106134. Epub 2020 Sep 1.
3
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk.抗MDA5抗体阳性皮肌炎中抗Ro52抗体的共存与快速进展性间质性肺病及死亡风险高度相关。
J Rheumatol. 2023 Feb;50(2):219-226. doi: 10.3899/jrheum.220139. Epub 2022 Jun 15.
4
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.多发性肌炎/皮肌炎相关间质性肺疾病中肌炎特异性自身抗体的综合评估
Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2.
5
Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis.皮肌炎高分辨率 CT 影像学表现及其与巨噬细胞活化的相关性的临床意义。
Rheumatology (Oxford). 2020 Oct 1;59(10):2829-2837. doi: 10.1093/rheumatology/keaa034.
6
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.抗 MDA5 阳性伴间质性肺病的无肌病性皮肌炎中抗 Ro52 抗体的预后价值。
Rheumatology (Oxford). 2021 Jul 1;60(7):3343-3351. doi: 10.1093/rheumatology/keaa786.
7
The efficacy and safety of tofacitinib in anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis associated interstitial lung disease: a systematic review and meta-analysis.托法替布治疗抗黑色素瘤分化相关基因 5 抗体阳性皮肌炎相关间质性肺病的疗效和安全性:系统评价和荟萃分析。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241294000. doi: 10.1177/17534666241294000.
8
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.抗黑色素瘤分化相关基因5抗体低阳性滴度与皮肌炎患者间质性肺病的长期不良预后无关。
Respir Investig. 2018 Nov;56(6):464-472. doi: 10.1016/j.resinv.2018.07.007. Epub 2018 Aug 24.
9
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.抗 MDA5 抗体阳性皮肌炎相关间质性肺病患者血清几丁质酶水平的临床意义。
J Rheumatol. 2019 Aug;46(8):935-942. doi: 10.3899/jrheum.180825. Epub 2019 May 15.
10
Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease.抗黑色素瘤分化相关基因 5 抗体阳性皮肌炎伴间质性肺病患者死亡风险的预处理评估预测模型。
Front Immunol. 2022 Sep 23;13:978708. doi: 10.3389/fimmu.2022.978708. eCollection 2022.

本文引用的文献

1
A New Global Definition of Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征的新全球定义。
Am J Respir Crit Care Med. 2024 Jan 1;209(1):37-47. doi: 10.1164/rccm.202303-0558WS.
2
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study.皮肌炎合并间质性肺疾病的临床特征:一项回顾性病例对照研究
Rheumatol Ther. 2023 Jun;10(3):635-648. doi: 10.1007/s40744-023-00540-6. Epub 2023 Feb 18.
3
Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCT.
抗黑色素瘤分化相关基因 5 阳性皮肌炎患者的快速进展性间质性肺病:HRCT 的系列变化。
Emerg Radiol. 2022 Dec;29(6):961-967. doi: 10.1007/s10140-022-02080-y. Epub 2022 Aug 2.
4
Management of interstitial lung disease (ILD) in myositis syndromes: A practical guide for clinicians.肌炎综合征中间质性肺病(ILD)的管理:临床医生实用指南。
Best Pract Res Clin Rheumatol. 2022 Jun;36(2):101769. doi: 10.1016/j.berh.2022.101769. Epub 2022 Jul 13.
5
MDA5 expression is associated with TGF-β-induced fibrosis: potential mechanism of interstitial lung disease in anti-MDA5 dermatomyositis.黑色素瘤分化相关基因5(MDA5)表达与转化生长因子-β(TGF-β)诱导的纤维化相关:抗MDA5皮肌炎间质性肺病的潜在机制
Rheumatology (Oxford). 2022 Dec 23;62(1):373-383. doi: 10.1093/rheumatology/keac234.
6
Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study.抗黑色素瘤分化相关基因5抗体阳性皮肌炎中间质性肺炎的定量CT分析:一项单中心回顾性研究
Clin Rheumatol. 2022 May;41(5):1473-1481. doi: 10.1007/s10067-021-06033-7. Epub 2022 Jan 16.
7
A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis.基于计算机断层扫描影像组学的抗MDA5阳性皮肌炎间质性肺疾病预测模型
Front Med (Lausanne). 2021 Nov 29;8:768052. doi: 10.3389/fmed.2021.768052. eCollection 2021.
8
The Value of Effective Lung Ventilation Area Ratio Based on CT Image Analysis Is a New Index to Predict the Shorter Outcome of Anti-melanoma Differentiation-Associated Protein 5 Positive Dermatomyositis Associated Interstitial Lung Disease: A Single-Center Retrospective Study.基于CT图像分析的有效肺通气面积比的价值是预测抗黑色素瘤分化相关蛋白5阳性皮肌炎相关间质性肺病较短预后的新指标:一项单中心回顾性研究。
Front Med (Lausanne). 2021 Oct 7;8:728487. doi: 10.3389/fmed.2021.728487. eCollection 2021.
9
A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis.一种新的 CT 评分方法预测了抗 MDA5 阳性皮肌炎相关间质性肺病的预后。
Sci Rep. 2021 Aug 23;11(1):17070. doi: 10.1038/s41598-021-96292-w.
10
A retrospective cohort study in Chinese patients with adult polymyositis and dermatomyositis: risk of comorbidities and subclassification using machine learning.一项针对中国成人皮肌炎和多发性肌炎患者的回顾性队列研究:使用机器学习方法分析合并症的风险和亚分类。
Clin Exp Rheumatol. 2022 Feb;40(2):224-236. doi: 10.55563/clinexprheumatol/i2xeao. Epub 2021 Jun 26.